Gurnick Expands Nuc Med Program to Florida

December 19, 2024 04:00 PM PST | By EIN Presswire
 Gurnick Expands Nuc Med Program to Florida
Image source: EIN Presswire

Gurnick Academy officially expands its Nuclear Medicine Technology program. The school just received the green light to offer the program in Florida. SAN JOSE, CA, UNITED STATES, December 19, 2024 /EINPresswire.com/ -- Gurnick Academy of Medical Arts officially expands its Nuclear Medicine Technology program across Florida. According to the school, administrators just received the green light to offer the program in the “Sunshine State.” The school states that this opportunity will enable more students to pursue studies in nuclear medicine technology, expanding access to this specialized field.

Just this week, The Joint Review Committee on Educational Programs in Nuclear Medicine Technology (JRCNMT) approved clinical affiliates for the nuclear medicine technology program. We have clinical affiliates in Sarasota, Fort Myers, and Cape Coral.

“I am extremely proud of the nuclear medicine team for their hard work and dedication in achieving this milestone,” says Sarah Gibbons, Nuclear Medicine Program Director, of the good news. “Becoming approved in Florida is a pivotal step toward addressing underserved areas and tackling the technologist workforce shortage,” continues Gibbons. “We are thrilled to bring our top nuclear medicine educators to communities across America that currently lack access to accredited nuclear medicine programs.”

Nuclear medicine integrates principles of physics, chemistry, and mathematics to utilize small amounts of radioactive drugs, known as radiopharmaceuticals, for examining the human body at the molecular level.

Utilizing key partnerships established with clinical sites across California and online capabilities, Gurnick launched the program in the Spring of 2022. Since then, the course has received abundant support from the medical community. Moreover, the program is accredited by the Accrediting Bureau of Health Education Schools (ABHES) and the JRCNMT.

“This advancement and support of our clinical partners across the United States has been an important part of our development and connection to the healthcare community,” says Burke Malin, Gurnick Academy COO. “In particular, forging deeper relationships with our partners has allowed for more meaningful and collaborative planning,” concludes Malin. “This ability to work and create specific solutions with our employer partners is fundamental to our responsiveness to the medical imaging marketplace.”

Program advancements come at a fortuitous time, with national job outlooks for the field only expected to grow. According to the Bureau of Labor and Statistics, forecasts for nuclear medicine technologists are predicted to expand five (5) percent faster than other national averages between 2019–2029. Additionally, nuclear medicine technologists have a significantly greater ROI than other similarly situated program professionals. Further, the vocation receives high rankings within multiple core employment areas.1

Many schools are unable to offer instruction in this specialized modality due to the unique demands of the course load and the level of expertise required, according to school officials of the 24-month.*

Do you think you might be interested in a career in nuclear medicine technology? Consider taking the career training readiness quiz here.~

*96 Weeks Approved Instruction

Citation
1 “Nuclear Medicine Technologist Ranks among Best Jobs of 2020.” Money.usnews.com. (Accessed December 8, 2024.)

Cindy R Chamberlin, SEO Content Specialist
Gurnick Academy of Medical Arts
+1 559-495-9246
email us here
Visit us on social media:
Facebook
X
LinkedIn
Instagram

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next